Rare diseases
Investigational molecules
Locations
Back to France3 332 clinical trials in Corbeil Essonnes, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Sotatercept for Patients with Severe Pulmonary Arterial Hypertension at High Risk of Mortality
FranceStudy Comparing Radiotherapy Alone to Radiotherapy with Cisplatin for Patients with Sinus or Salivary Gland Tumors
FranceStudy of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration
FranceStudy of Belantamab Mafodotin Alone and with Drug Combination for Patients with Relapsed/Refractory Multiple Myeloma
FranceStudy on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis
FranceStudy on Pembrolizumab and Olaparib for Patients with Resectable Soft Tissue Sarcoma
FranceTitle: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment
FranceStudy of Domvanalimab, Zimberelimab, and Chemotherapy for Patients with Advanced Esophageal or Gastric Cancer
FranceStudy of JDQ443, TNO155, and Tislelizumab for Patients with Advanced Solid Tumors with KRAS G12C Mutation
FranceStudy on the Long-Term Safety of Nintedanib for Children and Adolescents with Interstitial Lung Disease
FranceStudy of EGL-001 for Adults with Advanced or Metastatic Solid Tumors
FranceStudy on the Effects of Selgantolimod and NUC Discontinuation in Patients with Chronic Hepatitis B
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on novel treatments for Type 1 and Type 2 Diabetes, particularly investigating therapies like tirzepatide for glycemic control and cardiovascular outcomes in patients with obesity and diabetes.
Groundbreaking trials in Multiple Myeloma treatment, evaluating combinations of targeted therapies including elranatamab, lenalidomide, and daratumumab for newly diagnosed and relapsed cases.
Research examining innovative treatments for Immune Thrombocytopenia, Polymyalgia Rheumatica, and Lupus Nephritis, focusing on targeted therapies and steroid-sparing approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
